We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
EOG Resources
EOG
$78B
| $306M | 0.45% |
2,714,463
-19,264
| -0.7% | -$2.16M |
|
77
Aon
AON
$77.3B
| $301M | 0.44% |
1,124,939
+36,970
| +3% | +$10.5M |
|
78
HCA Healthcare
HCA
$84.8B
| $301M | 0.44% |
1,635,588
+60,404
| +4% | +$12M |
|
79
Entergy
ETR
$54.1B
| $296M | 0.43% |
5,873,110
+849,344
| +17% | +$48.7M |
|
80
FMC
FMC
$1.42B
| $295M | 0.43% |
2,792,248
-445,580
| -14% | -$48.1M |
|
81
BWX Technologies
BWXT
$16B
| $290M | 0.42% |
5,736,873
+74,045
| +1% | +$4M |
|
|
SGI
82
Somnigroup International
SGI
$15.1B
| $289M | 0.42% |
11,956,347
+538,544
| +5% | +$14M |
|
83
Applied Materials
AMAT
$426B
| $282M | 0.41% |
3,429,557
-141,604
| -4% | -$13.7M |
|
84
Check Point Software Technologies
CHKP
$13.3B
| $279M | 0.41% |
2,486,020
+138,970
| +6% | +$16.8M |
|
85
Elevance Health
ELV
$81.9B
| $277M | 0.41% |
609,738
-24,997
| -4% | -$12M |
|
86
Zimmer Biomet
ZBH
$17.7B
| $276M | 0.4% |
2,643,998
-148,395
| -5% | -$16.3M |
|
87
Parker-Hannifin
PH
$125B
| $271M | 0.4% |
1,119,196
+63,512
| +6% | +$17.2M |
|
88
Union Pacific
UNP
$183B
| $263M | 0.39% |
1,351,431
+280,897
| +26% | +$62.2M |
|
89
Amgen
AMGN
$203B
| $260M | 0.38% |
1,151,340
-29,919
| -3% | -$7.25M |
|
90
Globe Life
GL
$13.5B
| $254M | 0.37% |
2,546,278
+54,819
| +2% | +$5.5M |
|
91
Whirlpool
WHR
$2.42B
| $253M | 0.37% |
1,880,330
+53,869
| +3% | +$8.58M |
|
92
Polaris
PII
$4.15B
| $253M | 0.37% |
2,646,911
+76,223
| +3% | +$8.54M |
|
93
Halliburton
HAL
$27.9B
| $245M | 0.36% |
9,951,333
+998,022
| +11% | +$28.5M |
|
94
CRH
CRH
$66.7B
| $242M | 0.35% |
7,474,936
+803,876
| +12% | +$29.2M |
|
95
Landstar System
LSTR
$6.8B
| $241M | 0.35% |
1,664,888
+368,802
| +28% | +$54.9M |
|
96
Nexstar Media Group
NXST
$5.6B
| $240M | 0.35% |
1,434,419
+66,106
| +5% | +$12.3M |
|
97
Dominion Energy
D
$62.5B
| $239M | 0.35% |
3,453,360
-262,094
| -7% | -$21.2M |
|
98
Curtiss-Wright
CW
$27.7B
| $236M | 0.35% |
1,677,849
+56,244
| +3% | +$7.98M |
|
99
Wabtec
WAB
$51.1B
| $234M | 0.34% |
2,870,779
-22,013
| -0.8% | -$1.94M |
|
100
RenaissanceRe
RNR
$13.7B
| $234M | 0.34% |
1,662,406
+941,897
| +131% | +$131M |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.